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Abstract
In October 2006, the Chief Medical Officer (CMO) of England asked Professor Sir John Tooke to
chair a High Level Group on Clinical Effectiveness in response to the chapter 'Waste not, want not'
in the CMOs 2005 annual report 'On the State of the Public Health'. The high level group made
recommendations to the CMO to address possible ways forward to improve clinical effectiveness
in the UK National Health Service (NHS) and promote clinical engagement to deliver this. The
report contained a short section on research needs that emerged from the process of writing the
report, but in order to more fully identify the relevant research agenda Professor Sir John Tooke
asked Professor Martin Eccles to convene an expert group – the Clinical Effectiveness Research
Agenda Group (CERAG) – to define the research agenda. The CERAG's terms of reference were
'to further elaborate the research agenda in relation to pursuing clinically effective practice within
the (UK) National Health Service'. This editorial presents the summary of the CERAG report and
recommendations.
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Background
In October 2006, the Chief Medical Officer (CMO) of Eng-
land asked Professor Sir John Tooke to chair a High Level
Group on Clinical Effectiveness in response to the chapter
'Waste not, want not' in the CMOs 2005 annual report 'On
the State of the Public Health'. The High level group made
recommendations to the CMO to address possible ways for-
ward to improve clinical effectiveness in the UK National
Health Service (NHS) and promote clinical engagement to
deliver this. The report contained a short section on research
needs that emerged from the process of writing the report,
but in order to more fully identify the relevant research
agenda Professor Sir John Tooke asked Professor Martin
Eccles to convene an expert group – the Clinical Effectiveness
Research Agenda Group (CERAG) – to define the research
agenda. The CERAG's terms of reference were 'to further elab-
orate the research agenda in relation to pursuing clinically
effective practice within the (UK) National Health Service'.
Terminology is a problem in both the practice of, and
researching into, clinical effectiveness. The high level group
uses the term 'clinical effectiveness' as it built on the termi-
nology used within the CMO's report. However, a study of
33 applied research funding agencies across nine countries
identified 29 terms used to refer to some aspect of the proc-
esses around clinically effective practice [1]. This confusion
has been compounded by the recent prominence of 'Trans-
lational Research', and the description of the first and sec-
ond translation gaps. Given the balance of scientific
endeavour and funding, the term 'Translational Research' is
mainly thought of as the T1 bench to bedside process of
transferring basic science knowledge into new drugs and
technologies. Attracting about 1% of the research funding
devoted to T1 research the T2 Translational Research is the
process of taking current scientific knowledge and ensuring
it is applied in routine clinical care [2].
Within the UK, the terms 'Implementation' and 'Imple-
mentation Research' seem to be the best recognised.
Therefore, as a focus for its deliberations the CERAG
adopted the following definition:
'Implementation Research is the scientific study of
methods to promote the systematic uptake of clinical
research findings and other evidence-based practices
into routine practice, and hence to improve the quality
(effectiveness, reliability, safety, appropriateness,
equity, efficiency) of health care. It includes the study
of influences on healthcare professional and organisa-
tional behaviour.' (adapted from Implementation Sci-
ence http://www.implementationscience.com/info/
about/ accessed 10 February 2009).
This editorial presents the summary of the group's report
and recommendations; the full report is available as Addi-
tional File 1.
The importance of Implementation Research 
and its funding
The findings from clinical and health services research can
not change population health outcomes unless health
care systems, organizations, and professionals adopt them
in practice [3]. A consistent finding is that the transfer of
research findings into practice is unpredictable and can be
a slow and haphazard process. The relative inattention to
implementing what we know is costing lives. There is an
imbalance between investment in the development of
new drugs and technologies versus improving the fidelity
with which care is delivered.
In a structured review of healthcare professionals views on
clinician engagement in quality improvement, Davies et
al. identified 86 empirical reports relevant to the review
[4]. They report that the literature suggests: healthcare
professionals are heterogeneous in relation to their defini-
tion of quality; their perception of the need for quality
improvement; their attitudes to quality improvement ini-
tiatives; their attitudes to clinical guidelines and evidence-
based practice. In addition, they have a limited under-
standing of the concepts and methods of quality improve-
ment, and quality improvement is often the scene of turf
battles. Under the heading of perceived barriers, they also
stated that 'many of the identified barriers arise from the
well-documented problems of working effectively
between and across health professions. This means that
although more time and more resources may be necessary
or helpful (directly and in their explicit recognition of
healthcare professionals' concerns), they are unlikely to
be sufficient on their own to overcome the substantial
barriers to clinicians' active engagement in successful
quality improvement'. Healthcare professionals are an
important part of the organisation in which they work
(and are subject to organisational policies, procedures,
and cultures); this review offers a partial explanation for
the persistent quality gaps and also supports the conten-
tion that it is unlikely that this will change spontaneously.
Recognition of quality gaps has led to increased interest in
more active implementation strategies. Over the past 10
years, a body of Implementation Research has developed
[5-7]. This demonstrates that interventions can be effec-
tive, but provides less information to guide the choice or
optimise the components of such complex interventions
in practice [8]. While the effectiveness of interventions
varies across different clinical problems, contexts, and
organizations, studies provide scant theoretical or concep-
tual rationale for their choice of intervention [9], and only
limited descriptions of the interventions and contextual
data [6]. Research on economic and political approaches
to change is scarce [10], and it is therefore not surprising
that little is known about how best to integrate disease
and case management interventions into existing health-
care at the system level. Thus, the science of Implementa-
Implementation Science 2009, 4:18 http://www.implementationscience.com/content/4/1/18
Page 3 of 7
(page number not for citation purposes)
tion Research is still a work in progress, largely due to the
fact that it is a relatively young science.
Internationally, Implementation Research is a recognised
area of funding within other healthcare systems; this is
not the case in the UK. The Cooksey Report [11] suggested
a UK annual research budget (Public sector and major
charities) of just over £2 billion. The proportion spent on
health services (as opposed to biomedical or clinical)
research in general is small. While there have been a
number of previous funding programmes for Implemen-
tation Research within the UK, none are current. The pro-
portion of annual research money devoted to
Implementation Research is impossible to quantify; it is
likely to be of the order of a maximum of a few millions
pounds per year.
The Cooksey Report [11], having identified the need for
implementation and Implementation Research, offers a
sound basis on which to elaborate the Implementation
Research agenda as a core part of a research agenda of key
relevance to the NHS.
One of the major problems with not having a clearly iden-
tified, named Implementation Research funding stream is
that the whole area loses 'profile'; the issues become
blurred and the central focus of the routine uptake of find-
ings, from clinical research programmes into routine care,
becomes lost to research enquiry. In countries where there
is a named, dedicated, funding stream (e.g., Canada, Aus-
tralia) the research area has a higher profile with both
researchers and with clinicians. There is the potential for
senior researchers to establish programmes of research
(rather than doing one-off studies), junior researchers to
make it a career choice, and clinicians to become willing
collaborators, thereby facilitating the spread of knowledge
and the improvement of methods.
Specific considerations for an Implementation 
Research agenda
In elaborating the Implementation Research agenda the,
CERAG identified five important overarching considera-
tions that should influence thinking about, and commis-
sioning of, Implementation Research.
First, it is important to consider the multiple levels at
which healthcare is delivered and the interplay between
them in their cultural context [12].
Second, Implementation Research centrally involves the
study of changing behaviour and maintaining change – in
organizations, and the groups and individual healthcare
professionals within them.
Third, the use of theory in Implementation Research
offers (at least) three important potential advantages. The-
ories offer a generalisable framework that can apply across
differing settings and individuals; they offer the opportu-
nity for the incremental accumulation of knowledge; and
they offer an explicit framework for analysis. The CERAG
agreed that appropriate consideration of theory was an
important element of Implementation Research. As well
as a more thoughtful use of theory, there is a need to work
through the various stages of using theory and resolving
such apparently simple issues as what it means for an
intervention to be theory-based or what is the theoretical
basis of behaviour change.
Fourth, frameworks are potentially useful tools for consid-
ering the issues that a research agenda needs to address
[13]. Inevitably there is no one ideal, universally accepted
framework that will fit all purposes; different frameworks
will often reflect different purposes, disciplinary, or phil-
osophical standpoints, and so will appeal to different
groups or individuals.
Fifth, a general complaint of implementation studies
(often trials) is that the need for experimental control,
maximising internal validity, compromises external valid-
ity. As ever, the balance of considering these two dimen-
sions of validity depends on the question that is being
answered at the time [14].
Who is this research agenda aimed at?
This discussion of the research agenda is aimed primarily
at commissioners of research, but will also be of relevance
to a broader range of policy makers and researchers. While
this report has been discussed and written in the context
of the UK National Health Service and the National Insti-
tute for Health Research (NIHR) it is possible that a vari-
ety of other research-commissioning organisations could
use it to identify areas that are a priority for them. How-
ever, it has been considered in its entirety and, in terms of
programmatic commissioning, a piecemeal approach to
addressing it could leave important areas unaddressed.
A Research Agenda
Research areas
Many of these research areas are interlinked. The CERAG
offered exemplar questions within each of them in order
to illustrate key issues. The processes suggested in the sub-
sequent recommendations will further elaborate and pri-
oritise the content of this agenda.
Context
The impact of context on implementation is important,
and systematic study of the attributes of context (and their
role and modifiability) that form barriers or facilitators to
implementation is needed. The responsiveness of context
is important in order to understand (and influence) cul-
ture and other attributes of organisations as well as the
individuals within them and their interests related to
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implementation of new knowledge. The role of context in
intervention development needs to be better understood.
Behavioural determinants and evaluation of change 
strategies
Successful implementation of new knowledge should be
built on an understanding of the determinants of behav-
ioural change and maintenance of behavioural change in
individuals and organisations. Such understanding would
allow the rational development and testing of implementa-
tion interventions. This should include the systematic devel-
opment of interventions and trials across a range of
conditions and NHS settings. These could include the study
of the organisational embedding of new interventions, the
effectiveness of healthcare system interventions, as well as
evaluation of delivering new models and methods of care.
There is a need for studies examining the methods of opti-
mising the content and methods of delivery of interventions.
Evaluations should use a range of (and often a combination
of) research designs and methods (e.g., cluster randomized
trials, quasi-experimental designs, and qualitative studies).
Testing of theory in Implementation Research
Theory is underused in Implementation Research. There
needs to be considerable work on understanding available
theories, on the testing and development of theories, and
on how to operationalise theory. This work should not be
restricted by disciplinary perspectives, worldview, or area
of application.
Knowledge attributes and knowledge generation – 
features related to uptake
Research is needed on the important attributes of new
knowledge and how these influence its uptake (or not).
This would include the attributes of and applicability of
what is regarded as evidence by different individuals and
in different contexts.
Decision makers have problems accessing, appraising,
adapting, and applying research evidence. The increasing
recognition that implementation of evidence from indi-
vidual studies may be misleading, either due to bias in
their conduct or random variations in findings, has led to
greater emphasis on knowledge syntheses as the basic unit
of implementation. Knowledge syntheses interpret the
results of individual studies within the context of global
evidence thus increasing the 'signal to noise ratio' of
implementation activities and increasing the likelihood of
their success. Knowledge syntheses provide the evidence
base for other implementation vehicles such as patient
decision aids, clinical practice guidelines, or policy briefs.
Systematic review activities (guided by relevant theory)
need to be supported systematically to ensure their con-
tinued development. Important areas activity include:
compiling and maintaining a register of systematic
reviews of Implementation Research; updating overviews
of reviews of professional behaviour change interven-
tions; conducting systematic reviews of methods to
improve the implementation of clinical research findings
in routine settings; workshops on conduct and use of
knowledge syntheses targeted to different stakeholders.
Cross-cutting issues
Methodology
Across all of the areas above there will be important meth-
odological issues that need to be identified, investigated,
and resolved. These include:
1. The area of Implementation Research needs a common
understanding of terms. Important areas of research
include: the development of one or more taxonomies of
barriers to implementation, mediating mechanisms and
pathways; standardised measurement approaches for key
elements of the taxonomy; a suite of reporting guidelines
for different types of Implementation Research.
2. All of the areas pose measurement challenges, such as
the development of process and outcome methods and
measures for relevant constructs.
3. Is there a 'core set' of measures that will be applicable
to most settings, or is each combination of patient team
and organisation conceptually unique? The idea of a core
set of measures offers greater potential for accumulation
of knowledge.
4. What are the pros and cons of using proxies for behav-
iour, such as written or web-based vignettes that simulate
clinical behaviours?
5. The incorporation of economic analysis within Imple-
mentation Research is not necessarily methodologically
challenging, but it is very uncommon and should be
encouraged and supported.
6. An explicit examination of the pros and cons of the use of
routinely available data to assess implementation. This
would include the availability of data and the specificity of
data in relation to the implementation of research evidence.
Are there situations where there is sufficient routinely availa-
ble data for economic modelling to demonstrate the viability
or otherwise of certain behaviour change strategies? How
complex can and should such modelling become?
Implementation Research across different areas of clinical practice
Implementation Research will be conducted in a range of clin-
ical areas. This needs to be done in a way that ensures contri-
bution to an incremental understanding of implementation.
Research in one clinical area should generate ideas and under-
standing that can be drawn on in other clinical areas.
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Knowledge infrastructure for Implementation
This links to 'knowledge attributes', (above) and is
addressed in the UK by initiatives such as the NHS
National Library for Health, the Cochrane Collaboration
and Social Care Online. Nonetheless, the process recom-
mended below could formally set out the knowledge
infrastructure for implementation. This would be an
important exercise in making explicit the content of an
infrastructure (staff, skills, and resources), its scale, and its
degree of current (and future) integration into routine
healthcare.
Sustainability
The consideration of sustainability permeates the research
agenda. It is important to have a healthcare workforce that
can sustain implementation in the clinical setting as a
matter of routine. It is important that we learn more about
the organisational/contextual factors that enable the sus-
tained use of evidence in practice. It is also important to
have a research workforce that can sustain the area of
Implementation Research.
Within research itself it is important to examine attributes
of sustainability (within individuals, teams, and organiza-
tions) and to develop methods to examine whether the
effects of interventions are sustained over time.
Communication strategy/engagement with the NHS
As part of integrating implementation and Implementa-
tion Research within the NHS it will be vital to develop an
explicit communication and engagement strategy.
Workforce issues
Capacity to do implementation
How should the NHS workforce (clinicians/practitioners
and managers) be trained (at both undergraduate and
postgraduate levels) in order to optimise their ability to
implement new knowledge (without doing harm, over-
spending, giving more to one patient than another, while
also stopping ineffective practices)?
What are effective engagement strategies to involve the
workforce in implementation?
What are the important attributes of the workforce that
enhance knowledge use and implementation in health-
care settings?
How can these attributes be sustained both within indi-
viduals and organisations?
Capacity to do Implementation Research
Capacity to do research into implementation is limited
both within the UK and internationally. The NIHR needs
a strategy of building capacity at all levels of the researcher
career. Given the time that it takes to build experience in
this area NIHR needs a cadre of experienced senior inves-
tigators who can direct programmes of research.
A funding strategy should also train junior researchers to
be capable of developing into independent researchers
(this should be linked with experience Implementation
Researchers). This could involve a mix of PhD student-
ships and fellowship awards.
Attributes of research teams addressing this agenda
Addressing this research agenda will be an inherently
multi- and inter-disciplinary endeavor. No one practice or
academic group or discipline will bring all the necessary
attributes to address the research agenda. The range of
required disciplines will vary within and across the vari-
ous areas of the research agenda, but is likely to include
some of Implementation Research, sociology, health psy-
chology, health economics, and statistics.
Implementation and evidence of benefit from clinical and 
public health interventions
It will most often be the case that the Implementation
Research agenda will be applied to areas where there is a
clear understanding of appropriate clinical care or public
health practice. In some areas there will be insufficient
published evidence to inform a clear, shared understand-
ing of optimum practice; in such instances the research
agenda should address the need for evidence of efficient
clinical and public health practice.
Recommendations
1. NIHR should initiate a process to establish a research
programme within NIHR with an explicit dedicated, pro-
tected, funding stream for funding Implementation
Research.
a. This process should detail issues such as:
i. the scope and prioritization of topics for such a
programme.
ii. the potential overlap with current national
research programmes within and outwith NIHR.
iii. the potential overlap with other NIHR funded
initiatives – National Library for Health, Collabo-
rations for Leadership in Applied Health Research
and Care (CLAHRCs), Cochrane Collaboration.
iv. the relevant stakeholders in the process.
v. the appropriate configuration of such a pro-
gramme of research – either as a single entity (max-
imising focus, scarce researcher resources, and
critical mass), or as a dimension of each of the cur-
rent national programmes (more diffuse, but
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probably more administratively straightforward to
establish).
vi. the establishment of a commissioning group
with appropriate expertise to evaluate proposals.
vii. the timescale for establishing launching and
commissioning research within such a pro-
gramme.
viii. relevant indicators of success for such a pro-
gramme to allow its evaluation.
b. Given the scale for return on investment and poten-
tial to save lives, this should aim to achieve a steady-
state annual budget of 2 to 3% of NIHR total research
budget. With total budget estimates at £750 million,
this equates to approximately £15 to 22 million.
c. Spending on this scale will not be achievable imme-
diately, and so the process should consider an escalat-
ing funding process starting at a lower level and
incrementally rising to the steady-state figure over a
number of years.
d. Long-term commitment is needed to deal with the
issue of creating a climate conducive to conducting
Implementation Research and the closely linked area
of using research findings in routine settings. Without
this being seen as both central and important, it is
unlikely to be sustained.
e. Consideration should be given to the idea of estab-
lishing one or more Centers of Implementation
Research Excellence along the lines of the Public
Health Centers of Excellence.
2. A mix of project and programme funding would allow
studies of a shorter and more 'worked through' nature, as
well as series of interlinked conceptual, methodological
work that is needed in the area.
3. The process of commissioning should be a mix of com-
missioner-defined and curiosity-driven. In such a rela-
tively young area, it is unlikely to be possible for a
commissioned research process to fully cover all relevant
areas, particularly in the areas of methodological and con-
ceptual work.
4. In order to enhance capacity development, a propor-
tion of the funding should be directed towards student-
ships, fellowships, and bursaries.
5. There should be consideration of the development of
training programmes for Implementation Researchers.
Although not a research budget cost, there should also be
consideration of the development of (pre- and post-regis-
tration) training programmes for clinicians and non-clini-
cians within the NHS around building capacity to better
use implementation (and clinical) research in daily prac-
tice.
6. Implementation Research and Implementation
Researchers need to be embedded within the NHS. One
way to achieve this would be to consider further strength-
ening and extending the Implementation Research
dimensions of the Collaboration in Applied Health
Research and Care centers. This should also consider how
to closely ally those researching implementation with
those doing implementation on a daily basis.
7. In order to advance the research area, funding should
be directed towards providing opportunities for scientists
and clinicians to meet to discuss relevant issues – akin to
the UK Economic and Social Research Council Seminar
Series Grants.
8. NIHR should give consideration to establishing a stand-
ing advisory group, with appropriate expertise, to con-
tinue to develop, oversee, and advise on Implementation
Research within the NHS. Such a body could also make
links with other national centers to form an international
network.
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